Aberdeen Group’s Nuvalent NUVL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.7M Sell
123,577
-41,600
-25% -$4.24M 0.02% 543
2025
Q4
$16.6M Buy
165,177
+88,489
+115% +$8.73M 0.03% 489
2025
Q3
$6.63M Hold
76,688
0.01% 672
2025
Q2
$5.85M Hold
76,688
0.01% 683
2025
Q1
$5.44M Buy
76,688
+19,987
+35% +$1.56M 0.01% 672
2024
Q4
$4.44M Buy
56,701
+9,241
+19% +$863K 0.01% 670
2024
Q3
$4.86M Sell
47,460
-40,233
-46% -$3.34M 0.01% 651
2024
Q2
$6.65M Buy
+87,693
New +$6.24M 0.01% 583

Other funds holding NUVL

Aberdeen Group's NUVL Position: Q1 2026 in Review

Aberdeen Group reduced its Nuvalent (NUVL) stake by 25% in Q1 2026, selling an estimated $4.24M and leaving 123,577 shares worth $12.7M. The position accounts for 0.02% of the portfolio, ranked #543.

Aberdeen Group first reported a position in NUVL in Q2 2024 and has held it in 8 quarters since. The position peaked at $16.6M in Q4 2025. 263 funds tracked by Wall St. Rank hold NUVL as of Q1 2026.

  • Aberdeen Group held 123,577 shares of Nuvalent worth $12.7M as of Q1 2026.
  • Aberdeen Group sold 41,600 Nuvalent shares in Q1 2026, an estimated $4.24M.
  • Nuvalent made up 0.02% of Aberdeen Group's portfolio in Q1 2026, its #543 holding.
  • Aberdeen Group first reported a position in Nuvalent in Q2 2024 and has held it in 8 quarters since.
  • Aberdeen Group's Nuvalent position peaked at $16.6M in Q4 2025.
  • 263 funds tracked by Wall St. Rank held Nuvalent as of Q1 2026.

Based on Aberdeen Group's 13F filing for Q1 2026, filed 29 Apr 2026.